151P Enhanced Pharmacodynamic Effects Upon Combination of Cibisatamab and FAP-4-1BBL in 3L+ Mmss CRC Patients I. Melero, T. Tanos, C. Heichinger, I. Davydov, A. Boehnke, N. Kumpesa, C. Ooi,V. Karanikas, M. Cannarile,I. Baraibar Argota,M. Martinez Garcia,V. Moreno Garcia,C. Qvortrup, T.W. Kim,S-H. Beom,M.G. Van Dongen, E. Calvo,M.C. Riesco Martinez,F. Thistlethwaite,V.K. WoodcockAnnals of Oncology(2024)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要